Contract for ENCORAFENIB (BRAFTOVI) 75mg Capsules
A Voluntary Ex-Ante Transparency (VEAT) Notice
by NORTHERN HEALTH AND SOCIAL CARE TRUST
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £162K
- Sector
- HEALTH
- Published
- 30 Jan 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Antrim
2 buyers
1 supplier
- Pierre Fabre Reading
Description
Contract for supply of ENCORAFENIB (BRAFTOVI) 75mg Capsules
Total Quantity or Scope
Contract for supply of ENCORAFENIB (BRAFTOVI) 75mg Capsules for up to a maximum of 36 months
Award Detail
| 1 | Pierre Fabre (Reading)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price and quality.
Legal Justification
Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement. The Northern Trust requires the purchase of Encorafenib 75mg capsules which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.
Reference
- FTS 003083-2024